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resistance as exempliﬁed by ﬂuconazole and echinocandins-
resistant Candida spp. This situation highlights the need
for advent of safe, novel and effective antifungal com-
pounds. The objective of this study was to determine
whether secondary metabolites produced by a species of
Streptomyces was able to exert antifungal effects against
seven and ﬁve medically important yeast Candida spp. and
molds Aspergilllus spp. respectively. NCCLS M27A and M38A
methods for MIC determination were followed stringently
in this screening procedure. Our initial work found all of
these fungi were susceptible to the crude fermentative
acetone extract (MIC ≤0.625mg/ml for Candida spp. and
≤2.5mg/ml for Aspergillus spp.). Five ﬂuconazole-resistant
clinical strains were also sensitive to it, with MIC val-
ues ≤0.312mg/ml. In addition, it also totally inhibited C.
albicans ATCC 14053 hyphae growth at 0.5mg/ml. These
promising results showed that potential antifungal com-
pounds from secondary metabolites were produced by this
species of Streptomyces. This work will be further tested
with fractionated extracts and the mechanism of action of
potential bioactive compounds will be elucidated.
doi:10.1016/j.ijid.2008.05.766
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Objective: To prospectively assess the Asian-Paciﬁc expe-
rience with caspofungin administered as monotherapy or
in combination therapy for initial or salvage treatment of
proven or probable invasive aspergillosis (IA).
Methods: A prospective observational registry was devel-
oped to collect data from patients treated with caspofungin
for a single episode of IA. Information was collected from
patients treated between April 2006 to September 2007.
Clinical efﬁcacy was determined by the local investigator as
favorable (complete or partial response) or unfavorable (sta-
ble disease or treatment failure) at the end of caspofungin
therapy (EOCT).
Results: Forty one patients with proven or probable
IA (EORTC/MSG criteria) were enrolled from 9 sites in 4
countries in the Asian-Paciﬁc region - Australia, Korea,
Singapore, and Taiwan. The most frequent underlying con-
ditions included malignancy (71%), allogenic hematopoietic
stem cell transplantation (HSCT, 30%), solid organ transplan-
tation (SOT, 14%) and autologous HSCT (2%). Neutropenia at
start of caspofungin was evident in 66% of cases. Eighteen
patients (44%) had proven IA and the lung was the most com-
mon infection site (73%). In culture-proven cases, Aspergillus
fumigatus was the most frequent species. The majority of
patients received caspofungin monotherapy (88%), primar-
ily as salvage therapy (97%). Most salvage therapy (77%) of
monotherapy group occurred in patients refractory to prior
antifungals. A favorable response at EOCT was seen in 46%
(19/41). Favorable response rates in signiﬁcant subgroups
were: SOT 67% (4/6); allogenic HSCT 42% (5/12); neutrope-
nia 37% (10/27); malignancy 35% (10/29). Only 1 serious
clinical adverse event (respiratory failure) leading to dis-
continuation of drug was reported (2.4%). An overall survival
rate was 68% (28/41) at EOCT.
Conclusion: In daily clinical practice, an overall favor-
able response rate of 46% was observed in patients from
Asian-Paciﬁc region with proven or probable IA treated with
caspofungin monotherapy or combination therapy which is
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Introduction: In patients with advanced AIDS, oropharyn-
geal candidiasis (OPC) continues to be a common presenting
illness associated with signiﬁcant morbidity. Resistance to
antimicrobial agents aggravates the implications for morbid-
ity and mortality and health care costs in the hospital and
the community. Studies in the USA have shown a correlation
between in vitro antifungal susceptibility testing with the
clinical outcome. In this study we determine and document
the type species and the antifungal susceptibility patterns of
organisms causing OPC among HIV+ adult medical admissions
to Mulago Hospital, Kampala.
Methods: Fifty (50) isolates were obtained from 57 con-
secutive isolates among immune suppressed patients at
Mulago hospital, Kampala. The isolates were identiﬁed using
germ tube formation in serum, chlamydospore formation
and API20C strips. Antifungal susceptibilities were deter-
mined for Nystatin, ﬂuconazole, ketoconazole, miconazole,
Itraconazole, 5- ﬂucytocine and voriconazole using calori-
metric broth microdilution testing.
Results: Ninety percent (90%) of all isolates were C. albi-
cans species, 58% of which were isolated from hyperplastic
lesions. C. dubliniensis and C. glabrata comprised 6% and 4%
of all isolates respectively. Overall the isolates were sensi-
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tive to all the antifungal drugs tested. The most efﬁcacious
antifungal was voriconazole and the least efﬁcacious was
nystatin. Ketoconazole was eight times more potent than
ﬂuconazole.
Conclusion and recommendations: All antifungals tested
are still efﬁcacious in the treatment of OPC. The Ugandan
Ministry of Health and international donors should consider
availing more ketoconazole than Fluconazole since the for-
mer is several times more superior. Furthermore, there
should be continued monitoring of the susceptibility pat-
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Cryptococcus neoformans is an opportunistic fungal
pathogen that often cause the signiﬁcant illness and death
among persons with AIDS. The rapid and accurate identiﬁca-
tion of Cryptococcus neoformans in the clinical laboratory
based on the phenoloxidase activity of the organism and
there are several media used in this test. We have brought
the Pal’s medium (Sunﬂower seed agar) to apply for testing
of phenoloxidase activity of C. neoformans clinical isolates
from AIDS patients in Thailand. We improved the formula
and the preparation of Sunﬂower seed agar which appropri-
ate for the phenoloxidase activity test. Then the test was
conducted to the 100 clinical isolates of C. neoformans and
the ﬁndings was that it created the brown colony on the Sun-
ﬂower seed agar once it hit 16 hours. These brown colonies
could be read the positive result clearly after 24 hours. The
false positive and negative results were not found which
appeared to be the same in the test over the Modiﬁed caffeic
acid-cornmeal agar and DOPA medium. When comparing the
Sunﬂower seed agar to the other two agar media, the strong
point of the Sunﬂower seed agar is that the price per unit
is very cheap, the resource is easier to ﬁnd in Thailand and
the expiration is after 6 month. The hospital laboratories
all through the country can use this way without affecting
its original diagnosing charge but instead will increase the
value added to the service for medical doctors and patients.
doi:10.1016/j.ijid.2008.05.769
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Background: The mortality rate of HIV/AIDS patients with
fungal infections is substantially increasing. We proposed
ourselves to study the ethiology of fungal infections at a
group of patients with HIV/AIDS under antiretroviral ther-
apy.
Methods: the authors have studied 42 adult patients with
HIV/AIDS admitted in Department of Infectious Diseases
Timisoara, Romania. The positive diagnosis was established
based on the physical examination (prolonged feverish,
weight loss, malaise, peripheral lymphadenopathy, white
depots on the tongue, headache, photophobia etc.), biolog-
ical samples (number of leukocytes, leukocytary formula,
ESR, blood cultures, sputum cultures, ELISA test, Western
blot test, glossal exudate and culture on Sabouraud medium,
biochemical parameters of cerebrospinal ﬂuid (CSF), culture
of CSF on Sabouraud medium etc.) and direct microscopic
examination of fungal specimens.
Results: 15 pacients (46.87%) have presented glossal
candidiasis, 10 (31.25%) have had oropharyngial candidia-
sis, 3 patients (9.37%) with esophageal candidiasis, and 4
(12.5%) with acute meningitis; there have been isolated
18 strain (56.25%) of Candida albicans, 10 strain (31.25%)
of Candida nonalbicans from wich 3 Candida glabrata, 2
Candida keﬁr, 3 Candida krusei and 2 Candida parapsilo-
sis. Cryptococcus neoformans were detected to all patients
(4) with acute meningoencephalitis. Out of 18 strain of
Candida albicans, 5 have been resistance to ﬂuconazole
and all with sensitivity to itraconazole. We mention that
all strain of Candida krusei have been resistance to ﬂu-
conazole and with sensitivity to itraconazole. The isolation
of these species, along with the sensitivity at antifungal
drugs test have allowed an antifungal treatment with sat-
isfying results. The patients with oropharyngial candidiasis
had CD4 between 250—350/mmc, the ones with esophageal
candidiasis between 250—220CD4/mmc and the ones with
Criptococcus meningitis under 220CD4/mmc.
Conclusion: Candida albicans remain the main ethio-
logic agent for the oropharyngial fungal infections and
Cryptococcus neoformans is the main agent of acute menin-
goencephalitis in adults with HIV/AIDS.
doi:10.1016/j.ijid.2008.05.770
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Background: This study aimed to investigate species dis-
tribution and in vitro drugs susceptibility of Candida sp.
isolates from HIV positive patients.
Methods: We studied the frequency of resistance proﬁle
to amphotericin B, ﬂucytosine, ﬂuconazole and itraconazole
of 50 isolates of Candida sp. from newly diagnosed AIDS
patients with oropharyngeal candidiasis at Shanghai Public
Health Clinical Center, using Neo-Sensitabs tablet assay. We
reviewed English language papers pertinent to oropharyn-
geal candidiasis in HIV positive patients.
